Showing results (1471-1480 of 5,347) with videos related to

Sort By:
Pageof 535
Japanese Journal of Clinical Oncology|June 1, 2006
Comparison of observed and expected numbers of detected cancers in the research center for cancer prevention and screening programChisato Hamashima, Tomotaka Sobue, Yukio Muramatsu, et al.
Japanese Journal of Clinical Oncology|May 28, 2020
Real-world use of temsirolimus in Japanese patients with unresectable or metastatic renal cell carcinoma: recent consideration based on the results of a post-marketing, all-case surveillance studyShigeru Sugiyama, Kazuo Sato, Yoshiyuki Shibasaki, et al.
Japanese Journal of Clinical Oncology|May 29, 2020
Initial evaluation of nivolumab in patients with post-operative recurrence of malignant pleural mesotheliomaAkifumi Nakamura, Nobuyuki Kondo, Toru Nakamichi, et al.
Japanese Journal of Clinical Oncology|May 29, 2020
Temozolomide and etoposide combination for the treatment of relapsed osteosarcomaRyo Akazawa, Katsutsugu Umeda, Satoshi Saida, et al.
Japanese Journal of Clinical Oncology|May 30, 2020
Prognostic significance of non-urothelial carcinoma of bladder: analysis of nationwide hospital-based cancer registry data in JapanYoshiyuki Nagumo, Koji Kawai, Takahiro Kojima, et al.
Japanese Journal of Clinical Oncology|May 7, 2021
Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment*Hajime Yonezawa, Makoto Ohno, Hiroshi Igaki, et al.
Japanese Journal of Clinical Oncology|May 14, 2021
The current status of inpatient cancer rehabilitation provided by designated cancer hospitals in JapanTakuya Fukushima, Tetsuya Tsuji, Noriko Watanabe, et al.
Japanese Journal of Clinical Oncology|May 19, 2021
Guideline adherence for radical cystectomy significantly affects survival outcomes in non-muscle-invasive bladder cancer patientsEmina Kayama, Keisuke Shigeta, Eiji Kikuchi, et al.
Japanese Journal of Clinical Oncology|June 18, 2020
Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fibrosis: a phase III study evaluating survival (JCOG1708, SURPRISE)Kiyo Tanaka, Yasuhiro Tsutani, Masashi Wakabayashi, et al.
Japanese Journal of Clinical Oncology|June 18, 2020
Cumulative cigarette tar exposure and lung cancer risk among Japanese smokersKeiichi Shimatani, Hidemi Ito, Keitaro Matsuo, et al.
Pageof 535